XML 42 R19.htm IDEA: XBRL DOCUMENT v3.8.0.1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2018
Accounting Policies [Abstract]  
Summary of Product Revenue by Geographical Locations of Customers

Product revenue by geographical locations of customers during the three months ended March 31, 2018 and 2017, were as follows (in thousands):

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2018

 

 

2017

 

Product revenue:

 

 

 

 

 

 

 

 

North America

 

$

2,387

 

 

$

1,065

 

Europe, Middle East and Africa

 

 

11,006

 

 

 

5,911

 

Other

 

 

171

 

 

 

30

 

Total product revenue

 

$

13,564

 

 

$

7,006

 

 

Summary of Changes in Contract Liabilities

The changes in the contract liabilities during the three months ended March 31, 2018 and 2017, were as follows (in thousands):

 

Beginning

 

 

 

 

 

 

 

Ending

 

Contract Liabilities

Balance

 

Additions

 

Deductions

 

Balance

 

Three months ended March 31, 2018

 

 

 

 

 

 

 

 

 

 

 

 

Deferred product revenue - current

$

445

 

$

662

 

$

(468

)

$

639

 

Deferred product revenue - non current

 

15

 

 

 

 

(8

)

 

7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended March 31, 2017

 

 

 

 

 

 

 

 

 

 

 

 

Deferred product revenue - current

$

149

 

$

634

 

$

(313

)

$

470

 

Deferred product revenue - non current

 

46

 

 

 

 

(8

)

 

38

 

 

Anti-Dilutive Effect of Common Shares

The table below presents shares underlying stock options, restricted stock units, and employee stock purchase plan rights that were excluded from the calculation of the weighted average number of shares outstanding used for the calculation of diluted net loss per share. These are excluded from the calculation due to their anti-dilutive effect for the three months ended March 31, 2018 and 2017 (shares in thousands):

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2018

 

 

2017

 

Weighted average number of anti-dilutive potential shares:

 

 

 

 

 

 

 

 

Stock options

 

 

17,879

 

 

 

16,669

 

Restricted stock units

 

 

1,579

 

 

 

966

 

Employee stock purchase plan rights

 

 

92

 

 

 

 

Total

 

 

19,550

 

 

 

17,635